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Abstract
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Epileptogenesis in mesial temporal lobe epilepsy is determined by several factors including
abnormalities in the expression and function of ion channels. Here, we report a long-lasting deficit
in gene expression of Kcnma1 coding for the large-conductance calcium-activated potassium (BK,
MaxiK) channel α-subunits after pilocarpine-induced status epilepticus. By using comparative realtime PCR, Taqman gene expression assays, and the delta-delta comparative threshold method we
detected a significant reduction in Kcnma1 expression in microdissected dentate gyrus at different
intervals after status epilepticus (24 h, 10 days, 1 month, and more than 2 months). BK channels are
key regulators of neuronal excitability and transmitter release. Hence, defective Kcnma1 expression
may play a critical role in the pathogenesis of mesial temporal lobe epilepsy.
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Introduction
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Large-conductance Ca2+-activated K+ (BK, MaxiK, slo1) channels and accessory β-subunits
(i.e. β3 and β4) have been recently implicated in the pathogenesis of genetic and acquired
epilepsy [1–5]. In the hippocampus, BK channels are expressed at presynaptic, somatic, and
dendritic locations where they are thought to play distinct roles in controlling neuronal intrinsic
excitability and transmitter release [6–9]. The distribution and function of BK channels make
these channels of especial interest for the pathogenesis of epilepsy [10–12]. Accordingly, we
have recently demonstrated a downregulation of BK channel α-subunits in the dentate gyrus,
specifically in the mossy fibers, of chronically epileptic rats [1]. Here, we performed
comparative real-time PCR analysis to detect quantitative differences in BK channel
(Kcnma1) gene expression at different time points after pilocarpine-induced status
epilepticus (SE).

Methods
All experiments were performed in accordance with the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals and with the approval of The University
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of Texas at Brownsville Institutional Animal Care and Use Committee (Protocol #: 2007-001IACUC). Chronic epileptic rats were obtained by the pilocarpine model of temporal lobe
epilepsy following described procedures [13]. At the time of inducing SE, animals were
approximately 20–30 days (180–250 g). Methyl-scopolamine nitrate (0.1 mg/kg in saline,
subcutaneously.) (Sigma-Aldrich, St Louis, Missouri) was administered 30 min prior
pilocarpine to minimize the systemic side effects of cholinergic overstimulation [14]. Animals
were then injected with 4% pilocarpine hydrochloride (Sigma-Aldrich) (350 mg/kg in saline,
intraperitoneally). Age-matched controls included (i) animals that received methylscopolamine but were injected with saline instead of pilocarpine, (ii) pilocarpine-injected
animals that did not exhibit seizures. Behavioral SE was limited to approximately 3 h by
administering two doses of diazepam (10–12 mg/kg, subcutaneously, 6-h interval) to enhance
survival and allow rats to experience same amount of epileptogenic insult [15,16]. After SE,
rats were monitored for detecting of at least two spontaneous seizures (8 h/day) using a JVC
MiniDV digital video-camera and researcher-assisted SeizureScan software (Clever Sys., Inc,
Reston, Virginia, USA). For isolation of total RNA, pilocarpine-treated rats were anaesthetized
and killed at 24 h, 10 days, 1 month, and at more than 2 month (late chronic period) after
induction of SE. Total RNA isolation from microdissected dentate gyrus and cerebral cortex
(parietal area) were performed as reported earlier. Tissue was collected, weighed (about 20
mg), homogenized, and processed for total RNA isolation at 4°C using the RNAqueous-4PCR
Kit (Foster City, California, USA), following manufacturer's instructions. The concentration
and purity of total RNA for each sample was determined by the Quant-iT RNA Assay Kit and
Q32857 Qubit fluorometer (Carlsbad, Invitrogen, California, USA) and confirmed by optical
density measurements at 260 and 280nm using a BioMate 5 UV-visible spectrophotometer
(Thermo Spectronic, Waltham, Massachusetts, USA). The integrity of the extracted RNA was
confirmed by electrophoresis under denaturating condition [17]. RNA samples from each set
of control and epileptic rats were processed in parallel under the same conditions. RT were
performed on an iCycler Thermal Cycler PCR System (Bio-Rad Laboratories, Hercules,
California, USA), the High Capacity cDNA Reverse Transcription Kit (P/N: 4368814; Applied
Biosystems, ABI, California, USA) for synthesis of single-stranded cDNA. The cDNA
synthesis was carried out by following manufacturer's protocol using random primers for 1
μg of starting RNA. Each RT reaction contained 1000 ng of extracted total RNA template and
RT reagents. The 20 μl reactions were incubated in the iCycler Thermocycler in thin-walled
0.2-μl PCR tubes for 10 min at 25°C, 120 min at 37°C, 5 s at 85°C, and then held at 4°C. The
efficiency of the RT reaction and amount of input RNA template was determined by serial
dilutions of input RNA. Each RNA concentration was reverse transcribed using the same RT
reaction volume. The resulting cDNA template was subjected to quantitative real-time PCR
(qrtPCR) real-time using Taqman-based Applied Biosystems gene expression assays
Hs99999901_s1 for eukaryotic 18S rRNA (a common RNA mass normalizer) and
Rn99999916_s1 for endogenous control gene Glyceraldehyde 3 phosphate dehydrogenase 1
(Gapdh) of Rattus norvegicus and the TaqMan Fast Universal PCR Master Mix (ABI) and the
StepOne Real-Time PCR System (ABI). qrtPCR analysis of Kcnma1 mRNA expression were
carried out in a StepOne Real-Time PCR System using the validated TaqMan Gene Expression
Assays Rn01268575_m1 for target gene Kcnma1 (RefSeq: NM_031828.1) (amplicon
size=108 bp) and Rn99999916_s1 for the internal normalization gene GAPDH (amplicon
size=87 bp). For qrtPCR analysis, each sample was run in triplicates. Each run included a notemplate control to test for contamination of assay reagents. After a 94°C denaturation for 10
min, the reactions were cycled 40 times with a 94°C denaturation for 15 s, and a 60°C annealing
for 1 min. Three types of controls aimed at detecting genomic DNA contamination in the RNA
sample or during the RT or qrtPCR reactions were always included: a RT mixture without
reverse transcriptase, a RT mixture including the enzyme but no RNA, negative control
(reaction mixture without cDNA template). The data were collected and analyzed using
OneStep Software (ABI). Relative quantification was performed using the comparative
threshold (CT) method after determining the CT values for reference (Gapdh) and target
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(Kcnma1) genes in each sample sets according to the 2−ΔΔCt method (ΔΔCT, delta-delta CT)
[18] as described by the manufacturer (ABI; User Bulletin 2). Changes in mRNA expression
level were calculated after normalization to Gapdh. As calibrator sample we used cDNA from
arbitrarily selected control rat. The ΔΔCT method provides a relative quantification ratio
according to calibrator that allows statistical comparisons of gene expression among samples.
Values of fold changes in the control sample versus the post-SE samples represent averages
from triplicate measurements. Changes in gene expression were reported as fold changes
relative to controls. Data were analyzed by analysis of variance (ANOVA) (followed by posthoc analysis) or via paired t-test to check for statistically significant differences among the
groups (significance P value was set at <0.05).

Results
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In this study, we used a ΔΔCT relative quantification approach [18] of qrtPCR to assess seizurerelated changes in Kcnma1 gene expression after pilocarpine-induced SE. Relative
quantification was performed using Gapdh as endogenous control gene. As the analysis of gene
expression included different time-points after SE and animals with different age, we first
assessed age-dependent changes in Kcnma1 transcripts by performing relative quantification
in material obtained from age-matched control rats of different survival times. Our analysis
revealed no significant changes in Kcnma1 expression in control rats killed at different survival
periods corresponding with 24 h, 10 days, 1 month, and more than 2 months experimental
groups (three rats per group, ANOVA, P>0.05). Accordingly, data from six randomly selected
control rats were grouped together for statistical analysis. By using the ΔΔCT method of
relative quantification for qrtPCR, we detected significant changes in relative quantification
of gene expression of the target gene Kcnma1 (ANOVA, P<0.001, F=8.7) in the microdissected
dentate gyrus at different stages of epileptogenesis after pilocarpine-induced SE (Table 1, Fig.
1). A significant downregulation of Kcnma1 transcripts was noticed via post-hoc least
significant difference comparisons at all the different time points after pilocarpine-induced SE
as follows: 24 h: 21.6% reduction, P<0.05, n=4; 10 days (latent period): 32.7% reduction,
P<0.01, n=4; 1 month: 51% reduction, P<0.001, n=5; and at more than 2 months: 33.2%
reduction, P<0.001, n=5. In marked contrast to dentate gyrus, gene expression relative
quantification values for Kcnma1 were not significantly affected after SE (ANOVA P=0.06,
F=2.7) in the analysis performed using total RNA extracted from cerebral cortex as follows:
24=0.95±0.09, n=4; 10 days=1.05±0.11, n=4; 1 month=0.75±0.13, n=5; more than 2
months=0.79±0.22, n=5.

Discussion
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In a recent study, we demonstrated a downregulation of BK channel immunereactivity, protein
expression, and gene expression in the chronic phase of the pilocarpine model of epilepsy
[1]. Here, we report that deficit in Kcnma1 gene expression occurs as early as 24 h after
pilocarpine-induced SE and persist during the ‘latent’ period and late phases of epileptogenesis.
The role of BK channels in the pathogenesis of epilepsy remains controversial. Although, BK
channels is a potassium channel that should hyperpolarize the neurons, compelling data
indicate that gain-of-function of BK channels may increase intrinsic neuronal firing and lead
to hyperexcitability in genetic and acquired epilepsy [3,9,19,20]. A gain-of-function missense
mutation of BK channels has been implicated in the pathogenesis of a human syndrome
characterized by generalized epilepsy and paroxysmal dyskinesia [5]. Such mutation was
associated with abnormal calcium-dependent activation and possibly more rapid repolarization
of action potentials as functional changes that may lead to an increased brain excitability
[21]. Furthermore, BK channel b4 accessory subunit (Kcnmb4) knockout mice present
temporal lobe seizures emerging from dentate gyrus [3]. Interestingly, granule cells from b4
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knockout mice show a secondary gain-of-function for BK channels that sharpens action
potentials and supports higher firing rates that is thought to contribute to enhanced excitability.
In a recent study, picrotoxin-induced seizures provoke a gain-of-function in BK channel current
that is associated with abnormal, elevated network excitability in mice [20]. All together, it is
now widely accepted that upregulation of BK channel, probably at somatic and dendritic
locations, may enhance neuronal and network excitability and ultimately lead to seizures. It is
possible that spontaneous recurrent seizures can further ‘boost’ the function of remaining BK
channels in mesial temporal lobe epilepsy (MTLE), a phenomena that at the dentate gyrus may
result in enhanced neuronal excitability leading to more seizures. In this regards,
downregulation of Kcnma1 gene expression in dentate gyrus may represent a compensatory
plastic modification that opposes proepileptic changes in hippocampal ion channels leading to
hyperexcitability in MTLE.
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In contrast to the proepileptic effect of enhanced BK channel function, presynaptic BK channels
are considered to act as ‘emergency break’ to mitigate exacerbated glutamate release during
hyperactive states [7,10,11,22]. Indeed, presynaptic BK channels have been considered
pharmacological targets to prevent neurodegeneration and hyperexcitability [23,24]. In this
line, downregulation of BK channels in dentate gyrus may represent a proepileptic change
leading to exacerbated or uncontrolled glutamate release during epileptogenesis. We observed
significant reduction in kcnma1 transcripts as early as 24 h after SE, hence it is possible that
early deficit in BK channels may provoke sustained (apparently ‘silent’) hyperactivity of
excitatory pathways in the hippocampus that may contribute to the ongoing neurodegenerative
process in early epileptogenesis. In previous study, we demonstrate a dramatic reduction of
BK channel immunostaining in mossy fibers of chronically epileptic rats [1]. Interestingly,
compelling evidences from immunohistochemical studies indicate little or no expression of
BK channels in granule cells. BK channel current are large in magnitude, thus, it is possible
that only few channels in somatic location can affect the firing phenotype. Consequently, these
few somatic BK channels may remain probably undetected because of the sensitivity of the
current immunohistochemical approaches. Overall, downregulation of BK channels may exert
a dual effect whether at somatodendritic or presynaptic locations. Understanding how seizures
induce rearrangements in BK channel expression and function may shed light in the basic
mechanisms of epilepsy and lead to the development of novel antiepileptic drugs.

Conclusion
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Our data revealed a long-lasting downregulation of BK channel gene expression in dentate
gyrus after SE. These abnormalities can represent a compensatory phenomenon to attenuate
in intrinsic neuronal excitability but may also facilitate enhanced glutamate release at
hippocampal synapses that may further contribute to sustain the epileptogenic process in
MTLE. Functional implications of BK channel transcript downregulation deserve further
elucidation to decipher its role in epilepsy.
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Fig. 1.

Analysis of Kcnma1 gene expression after pilocarpine-induced status epilepticus (SE). (a).
Real-time RT-PCR analysis was performed for normalizing control gene (Gapdh) and targeted
gene Kcnma1 using the ÄÄCT method. Amplification plots of triplicates are shown for
representative experiments from four groups of pilocarpine-treated epileptic rats (amplification
curve indicated by arrow) sacrificed at different time points after SE versus controls as follows:
24 h: A1, 10 days: A2; 1 month: A3 and more than 2 months, A4.
ΔCT=CTControl−CTEpileptic for Kcnma1 at threshold, ÄRn, change in fuorescence. (b) Graph
representation of relative changes in gene expression of Kcnma1 after pilocarpine-induced
status epilepticus. Data presented as mean±SEM. Statistical analysis by ANOVA was
significant P<0.001. Post-hoc least significant difference comparisons relative to controls,
*P<0.05, **P<0.01, ***P<0.001.
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0.99±0.20

Control

ANOVA, analysis of variance.

Data are presented as mean±standard deviation.

Dentate gyrus

NIH-PA Author Manuscript
Table 1
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0.76±0.25

24 h
0.65±0.10

10 days
0.47±0.15

1 month

Post-status epilepticus period

0.64±0.10

>2 month

P<0.001, F=8.7

ANOVA

Relative quantification of Kcnma1 mRNA at different time points following pilocarpine-induced status epilepticus compared with
controls
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